Introduction
Heterotrimeric G-proteins link G-protein-coupled receptors to numerous intracellular signaling pathways.
The a 12 family of G protein a subunits function as regulators of cell growth and differentiation. Several studies have shown that both a 12 and a 13 can act as very powerful transforming agents (Jiang et al., 1993; Xu et al., 1993; Voyno-Yasenetskaya et al., 1994b) . In addition, Drosophila embryos carrying mutations in the concertina (cta) gene, the Drosophila homologue for a 12/ 13 , fail to undergo proper gastrulation, and lack of a 13 in mice results in embryonal death (day 9.5) due to severely impaired angiogenesis (Parks and Wieschaus, 1991; Offermanns, 2000) .
In the past years, the members of the a 12 family have been shown to function as regulators of a variety of cellular signaling pathways. a 12 and a 13 can activate the Na þ /H þ exchanger (Voyno-Yasenetskaya et al., 1994a) , the c-Jun NH2-terminal kinase (Prasad et al., 1995) , extracellular-signal-regulated kinases (ERK) (VoynoYasenetskaya et al., 1996) , tyrosine kinases (Mao et al., 1998a; Shi et al., 2000) , serum response element (SRE)-mediated gene transcription (Mao et al., 1998b) , stress fiber and focal adhesion formation (Buhl et al., 1995; Gohla et al., 1999) , neurite retraction (Katoh et al., 1998; Kranenburg et al., 1999) , and apoptosis (Althoefer et al., 1997; Berestetskaya et al., 1998) . Several of these pathways are mediated by the monomeric Rho GTPase, a member of the Ras superfamily of GTPases. a 13 activates Rho through direct stimulation of the guanine nucleotide exchange factor p115RhoGEF Kozasa et al., 1998) . Like all G-proteins, Rho cycles between the inactive GDP-bound and active GTP-bound form. RhoGEFs contain a Dbl-homology (DH) domain, which activates Rho by catalysing the exchange of GDP for GTP. p115RhoGEF, together with leukemia-associated RhoGEF (LARG) and PDZRhoGEF, comprise a subfamily of GEFs that contain a regulator of G-protein signaling homology (RH) domain. There are over 30 known regulators of G-protein signaling (RGS) proteins, almost all of which share the ability to switch off heterotrimeric G-proteins by functioning as GTPase activating proteins (GAP) for G-protein a subunits (Hollinger and Hepler, 2002) . The RH domain of p115RhoGEF serves as a binding site for a 12/13 and acts as a GAP specifically for the a 12 family of proteins. However, it is only a 13 that can activate p115RhoGEF's exchange activity on Rho. Thus, p115RhoGEF carries a dual function in its interaction with a 13 through its ability to catalyse the deactivation of a 13 by accelerating a 13 -GTP hydrolysis and also to mediate a 13 -induced Rho activation.
The mechanism through which a 13 is regulated by and activates p115RhoGEF is not clearly defined. Mutagenic analysis of p115RhoGEF has revealed a complex model where several regulatory mechanisms seem to be involved Wedegaertner, 2000, 2003a, b; Wells et al., 2001 Wells et al., , 2002a Chen et al., 2003) . Though the RH domain of p115RhoGEF shares low sequence identity with known RGS proteins, the crystal structure of the RH domain of p115RhoGEF revealed that the core of this domain shared significant structural similarity with the corresponding regions of RGS4 and RGS9 (Chen et al., 2001) . The crystal structure of the RGS4/a i1 complex has been solved and has revealed residues in the Switch I and Switch II segments of a i1 , which are known to undergo conformational changes upon GTP hydrolysis, to be the contact sites for RGS proteins (Tesmer et al., 1997) . The similarities between p115RH and other RGS proteins suggest that elements of the a/RGS interaction may be preserved in the interaction of a 13 with p115RhoGEF. Therefore, based on the crystal structure of the RGS4/ a i1 complex, studies on other a/RGS pairs, and sequence alignments of a i1 with a 13 , we targeted four specific residues of a 13 for mutagenesis. Analysis of these a 13 mutants revealed that mutating Glu229 to Lys in a 13 completely disrupted the ability of a 13 to interact with p115RhoGEF, induce PM recruitment of p115Rho-GEF, and stimulate Rho-dependent signaling. We also demonstrate that whereas mutating Lys204 to Glu and Arg232 to Glu disrupted the a 13 /p115RhoGEF interaction, as revealed by our GST-p115RH pulldown and coimmunoprecipitation assays, these mutations did not fully disrupt a 13 -induced PM translocation of p115Rho-GEF and Rho-dependent signaling. Thus, the a 13 / p115RhoGEF interaction is generally similar to a typical a/RGS interaction. However, in contrast to other a/RGS interactions, the substitution of a conserved glycine for a serine (G205S), termed an RGSinsensitive mutation in other a subunits , had no effect on the ability of a 13 to interact with and activate p115RhoGEF. In addition, we present the surprising result that the double mutations K204E/E229K and E229K/R232E partially rescue function of a 13 .
Results
Identification of a 13 residues that are critical for the interaction with p115RhoGEF
The structural similarity between the core domain of p115RH and RGS4 suggests that the a 13 /p115RhoGEF interaction might mimic the a i1 /RGS4 interaction. The crystal structure of the a i1 /RGS4 complex identified a i1 residues Thr182, Glu207, and Lys210 as important contact sites for RGS4, and Glu207 also appears to play a critical role in orienting the side chains of Thr182 and Lys210 (Tesmer et al., 1997) . These residues correspond to a 13 Lys204, Glu229, and Arg232, respectively, as revealed by sequence alignments of the two proteins (Figure 1 ). To determine residues in Ga 13 that define its interaction with p115RhoGEF, we mutated the above a 13 residues to an opposite charge (K204E, E229K, and R232E) and also to alanines (K204A, E229A, and R232A). In addition, a conserved glycine at position 205 was substituted for a serine (G205S), since this mutation has been shown to disrupt the interaction of Gpa1 (yeast Ga), a q , a i , and a o , with RGS proteins Lan et al., 1998) .
HEK293 cell lysates expressing HA-tagged a 13 wt and mutants were incubated with purified p115RH fused to GST (GST-p115RH) on glutathione agarose beads, in the presence or absence of AlF 4
À is known to reversibly activate a subunits by binding to a-GDP and inducing a conformation similar to that of the transition state for GTP hydrolysis (Coleman et al., 1994) . The ability of a 13 wt and mutants to bind to GST-p115RH was determined by immunoblotting with an anti-HA antibody. In the presence of AlF 4 À , GST-p115RH was able to efficiently pull down a 13 wt (Figure 2a ). Interestingly, a 13 G205S was also strongly pulled down by GSTp115RH in the presence of AlF 4 À (Figure 2a , left panel). Thus, the G205S mutation, though it disrupts RGS interactions for several a subunits, had no effect on the ability of a 13 to bind GST-p115RH, indicating differences between the a 13 /p115RH interaction and other a/RGS interactions. GST-p115RH very weakly pulled down AlF 4 À -activated a 13 K204E, suggesting that this mutant is severely defective in its interaction with GSTp115RH. a 13 E229K was not detected in the pulldown in the presence of AlF 4 À , indicating that it is unable to interact with GST-p115RH. Also, the a 13 R232E mutant has a strongly reduced ability to interact with GSTp115RH, as revealed by the very small amount of AlF 4 À -activated a 13 R232E pulled down by GST-p115RH ( Figure 2a, left panel) . In addition, the double mutants a 13 K204E/E229K, a 13 K204E/R232E, a 13 E229K/R232E and a construct containing all three mutations (a 13 T) were also not pulled down by GST-p115RH (Figure 2a , middle panel). To further understand the structural determinants for the a 13 /p115RH interaction, we also investigated the effects of mutating a 13 residues Lys204, Glu229, and Arg232 to alanines. Interestingly, a 13 E229A and a 13 R232A were efficiently pulled down by GST-p115RH, whereas a 13 K204A showed a very weak pulldown (Figure 2a, right panel) . Thus, the Figure 1 Alignment of a 13 with a i1 . The amino acids 179-222 of a i1 and 200-244 of a 13 are shown. a 13 residues that were mutated in this study have been marked by asterisks Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner primary role for Glu229 and Arg232 seems to be charge complementarity, whereas for Lys204 both charge and size seem to be important. All of the opposite charge mutants were also introduced in the constitutively activated form of a 13 , where a conserved glutamine (Q226) has been mutated to a leucine (a 13 QL) (Voyno-Yasenetskaya et al., 1994a) . Constitutively active a 13 QL and a 13 G205S QL were efficiently pulled down by GST-p115RH (Figure 3a) . a 13 K204E QL and a 13 R232E QL were weakly pulled down by GST-p115RH, whereas a 13 E229K QL was not detected in the pulldown (Figure 3a) . Thus, the constitutively activated point mutants mimic the behaviour of their AlF 4 À -activated forms in their interaction with GST-p115RH. Interestingly, even though a 13 E229K QL shows no interaction with GSTp115RH, the double mutants a 13 K204E/E229K QL and a 13 E229K/R232E QL were significantly pulled down by GST-p115RH. Thus, the charge reversal mutations K204E or R232E partially rescue the GSTp115RH-binding defect of a 13 E229K QL, but not of AlF 4 À -activated a 13 E229K. a 13 K204E/R232E QL is not pulled down by GST-p115RH, consistent with its AlF 4 À -activated form. The triple mutant varied in its ability to interact with GST-p115RH, suggesting that the triple mutations may affect the stability of this construct. These results with double mutants (Figure 3) are consistent with the possibility that Glu229, like Glu207 in a i1 (Tesmer et al., 1997) , functions, at least partly to stabilize other key residues. a 13 mutants that are defective in binding to are also defective in their interaction with full-length p115RhoGEF
To determine whether our a 13 mutations also prevented the interaction of a 13 with full-length p115RhoGEF, coimmunoprecipitations were performed. HEK293 cells were co-transfected with HA-tagged a 13 wt and mutants, along with a Myc-tagged p115RhoGEF, and immunoprecipitations with an anti-HA antibody were carried out to determine the ability of a 13 mutants to interact with p115RhoGEF ( Figure 4 ). p115RhoGEF was detected in the immunoprecipitation with AlF 4 À -activated a 13 wt and a 13 G205S, but not with AlF 4 À -activated Figure 3 Interaction of constitutively active a 13 mutants with GST-p115RH. HEK293 cells were transfected with the indicated a 13 QL constructs (2 mg) and pcDNA3 (1 mg). GST-p115RH (10 mg) immobilized on glutathione agarose beads was used to pull down a 13 QL or mutants. (a) a 13 QL or mutant pulldowns were detected by immunoblotting with anti-HA antibody. (b) Equal expression of a 13 QL mutants was determined by immunoblotting of cellular lysates with an anti-HA antibody. Results shown are representative of at least three independent experiments Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner a 13 K204E, a 13 E229K, and a 13 R232E (Figure 4a , left panel). Thus, consistent with the GST-p115RH pulldown assays, the G205S mutation has no effect on the ability of a 13 to interact with p115RhoGEF, whereas K204E, E229K, and R232E mutations disrupt the interaction. Also, as observed with the GST-p115RH interaction assays, no p115RhoGEF was detected in the immunoprecipitations with the double and triple mutants ( Figure 4a , middle panel), indicating that they are not able to bind to p115RhoGEF in the presence of AlF 4 À . p115RhoGEF was not co-immunoprecipitated with AlF 4 À -activated a 13 K204A, consistent with the GST-p115RH interaction assays ( Figure 4a , right panel), but p115RhoGEF was detected in the immunoprecipitations with AlF 4 À -activated a 13 E229A and a 13 R232A, though to reduced levels in comparison to a 13 wt (Figure 4a , right panel).
Activated a 13 E229K fails to promote PM translocation of p115RhoGEF G-protein a subunits are found in tight association with the plasma membrane (Neubig, 1994; Bhattacharyya and Wedegaertner, 2000) . p115RhoGEF is a cytoplasmic protein and it has been shown that a 13 QL-or GPCR-activated a 13 induces the translocation of p115RhoGEF from the cytoplasm to the plasma membrane (Bhattacharyya and Wedegaertner, 2000) . Upon GPCR activation, Rho has also been shown to translocate from the cytoplasm to the plasma membrane (Fleming et al., 1996; Kranenburg et al., 1997) . Thus, a 13 -induced p115RhoGEF translocation to the plasma membrane may be an important step in Rho activation. To determine how disruption of the a 13 /p115RhoGEF interaction affects a 13 -induced recruitment of p115Rho-GEF to the PM, HEK293 cells were co-transfected with the indicated constitutively active (QL) HA-tagged a 13 constructs and a GFP-tagged full-length p115RhoGEF. All constitutively active point mutants and the double mutants a 13 K204E/E229K QL and a 13 E229K/R232E QL were found in association with the PM, as indicated by the sharp staining at the cell periphery and lack of a nuclear shadow (Figure 5a -h, anti-HA). The PM localization of these constructs suggests that the structural integrity of these mutants is intact. On the other hand, a 13 K204E/R232E QL was characterized by a diffuse staining of the cytoplasm and the presence of a strong nuclear shadow (data not shown), whereas the triple mutant varied in its ability to localize to the PM (data not shown), corresponding to its varied ability to bind GST-p115RH. This inability to localize properly to the PM suggests that the double mutation a 13 K204E/ R232E and the triple mutation are detrimental to the structural folding and stability of a 13 . Figure 4 Interaction of a 13 mutants with p115RhoGEF. HEK293 cells were transfected with plasmids encoding for Myc epitopetagged p115RhoGEF and the indicated HA epitope-tagged a 13 constructs. At 48 h after transfection, cells were lysed and, as indicated, incubated in the presence ( þ ) or absence (À) of AlF 4 À . a 13 or its mutants were precipitated with an anti-HA monoclonal antibody. (a) Immunoprecipitated proteins were separated by SDS-PAGE and immunoblotted with a monoclonal antibody specific for the Mycepitope tag to determine the ability to a 13 mutants to bind p115RhoGEF (upper panel). Immunoprecipitated samples were also subjected to immunoblotting with anti-HA antibody to show equal amounts of immunoprecipitated HA-a 13 (lower panel). In the lower panel, the asterisks indicate HA-a 13 proteins, while the upper band corresponds to the antibody heavy chain. (b) Cell lysates were immunoblotted with an anti-Myc (upper panel) and anti-HA (lower panel) antibody to determine expression levels of Mycp115RhoGEF and HA-a 13 constructs, respectively. Results shown are representatives of at least three independent experiments Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner
As previously shown, when co-expressed with a 13 wt, p115RhoGEF displayed a diffuse cytoplasmic staining (Figure 5a , GFP) (Bhattacharyya and Wedegaertner, 2000) . a 13 QL, on the other hand, induced the translocation of p115RhoGEF to the PM, as evidenced by the sharp membrane staining and the lack of a nuclear shadow (Figure 5b , GFP). Similar to a 13 QL, the a 13 G205S QL mutant strongly promoted PM recruitment of p115RhoGEF, consistent with its ability to bind p115RhoGEF (Figure 5c , GFP). The lack of nuclear shadow and sharp membrane staining of p115RhoGEF when co-expressed with a 13 K204E QL demonstrate that this mutant also promotes the PM recruitment of p115RhoGEF (Figure 5d , GFP). When co-expressed with a 13 E229K QL, p115RhoGEF remained largely cytoplasmic, as indicated by the cytoplasmic staining decreasing in intensity towards the cell's periphery, and the strong nuclear shadow (Figure 5e , GFP). In addition, p115RhoGEF displayed both diffuse cytoplasmic staining and some sharp staining at the cell periphery when co-expressed with a 13 R232E QL (Figure 5f , GFP). The double mutants a 13 K204E/ E229K QL and a 13 E229K/E232E QL also show a reduced ability to promote PM recruitment of p115Rho-GEF, as indicated by the largely cytoplasmic staining of p115RhoGEF, but in contrast to the complete cytoplasmic staining of p115RhoGEF when co-expressed with a 13 E229K QL, p115RhoGEF displayed some sharp staining at the cell periphery when co-expressed with either of the two double mutants (Figure 5g-h, GFP) . Figure 5 Subcellular localization of p115RhoGEF in cells co-expressing constitutively active a 13 mutants. HEK293 cells were transiently co-transfected with 0.5 mg each expression plasmid for the indicated a 13 constructs and 0.1 mg DNA encoding p115RhoGEF-GFP. At 48 h after transfection, cells were fixed and stained with a monoclonal anti-HA antibody, followed by Alexa-594-conjugated anti-mouse antibody, to stain for the HA epitope-tagged a 13 constructs (anti-HA panels). p115RhoGEF's localization was determined by visualization of the intrinsic fluorescence of GFP (GFP panels), and DAPI staining was used to identify nuclei (DAPI panels). Three color-merged (color available in HTML version only) images show a 13 (red), p115RhoGEF-GFP (green), and nuclei (blue) (merged panels). A representative image of more than 100 cells analysed in three separate experiments is shown Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner Thus, consistent with our GST-pulldowns and coimmunoprecipitation assays, active a 13 mutants that are not fully defective in their ability to bind p115Rho-GEF also retain some of their ability to induce its PM recruitment.
a 13 mutants are deficient in inducing Rho-mediated signaling Since p115RhoGEF functions as the link between Ga 13 and RhoA, we wanted to determine whether the mutations in a 13 that disrupted binding to p115Rho-GEF in our GST-pulldown and immunoprecipitation assays also disrupt a 13 -induced Rho-mediated signaling. Activated G proteins a q/11 , a 12 , and a 13 have been shown to stimulate SRE-mediated gene transcription through RhoA-dependent activation of the serum response factor (SRF) (Mao et al., 1998b) . The ability of constitutively active a 13 mutants to activate Rhodependent signaling was determined using the SREmediated luciferase gene transcription assay, where HEK293 cells were transiently transfected with the constitutively active a 13 or mutants and a reporter plasmid that expresses the luciferase gene under the control of SRE. As previously shown, a 13 QL stimulated SRE-mediated luciferase gene transcription (Figure 6 ) (Bhattacharyya and Wedegaertner, 2000) . Co-expression of Clostridium botulinum C3 transferase, which has been shown to inhibit RhoA, completely blocked a 13 QL-induced SRE-mediated gene transcription, indicating that active a 13 is acting through RhoA (Mao et al., 1998c) . Consistent with the GST-p115RH pulldown, immunoprecipitation, and immunofluorescence studies, the G205S mutation had no effect on a 13 QL's ability to activate Rho-mediated SRE-luciferase gene transcription, delineating differences in the a 13 /p115RhoGEF interaction from other a/RGS interactions (Figure 6a ). The a 13 K204E QL and a 13 R232E QL mutants showed no statistical difference in their ability to stimulate SREluciferase gene transcription in comparison to a 13 QL, whereas a 13 E229K QL was strongly deficient (Figure 6a ). In all, 10 ng of each construct was transfected because this level of a 13 QL expression provided a robust signal, yet, importantly, was in the linear range of the response. The double mutants retained their ability to induce SRE-mediated luciferase gene transcription, corresponding to their behavior in the binding assays and immunofluorescence studies (Figure 6a ). To more closely examine whether there were any signaling defects in the p115RhoGEF binding-impaired a 13 K204E QL and a 13 R232E QL mutants, these mutants were expressed at varying levels (Figure 6b ). The a 13 K204E QL and a 13 R232E QL mutants were deficient in their ability to stimulate SRE-luciferase gene transcription in comparison to a 13 QL only when lower amounts (2.5 or 5 ng) were transfected (Figure 6b) . Thus, consistent with the binding assays, all three mutants are defective in stimulating Rho-dependent signaling, but a 13 E229K QL is most deficient in comparison to a 13 K204E QL, and a 13 R232E QL. a 13 point mutations do not affect heterotrimer formation or interaction with PP5-tetratricopeptide repeat domain (TPR)
In its inactive state, the GDP-bound a subunit is found as a heterotrimeric complex with bg subunits (Hamm, 1998) . G-protein-coupled receptor activation results in the dissociation of the GTP-bound a subunit from the bg dimers, and the subsequent activation of their respective effectors. To ensure that our mutations did not affect the proper structural folding and stability of a 13 , we first looked at the ability of these mutants to form heterotrimers. HEK293 cells stably expressing Figure 6 SRE-mediated gene transcription by constitutively active a 13 mutants. (a) pSRE-Luc (0.05 mg) and pCMV-bgal (0.1 mg) were cotransfected into HEK293 cells with either 0.85 mg of pcDNA3 (vector) alone, or with 0.84 mg pcDNA3 and 10 ng of the indicated a 13 constructs. C3-transferase (25 ng) was also co-expressed with a 13 QL as indicated. (b) HEK293 cells were cotransfected with 2.5-25 ng of a 13 constructs as indicated, and pSRE-Luc, pCMV-bgal, and pcDNA3. Cells were lysed 24 h after transfection, and assayed for luciferase activity and b-galactosidase activity. Luciferase activity was normalized by the b-galactosidase activity present in each lysate. Results are presented as percentage activity with respect to control cells (vector) and are the means7s.e. of results obtained from (a) three independent experiments performed in duplicate (N ¼ 6) or (b) two independent experiments performed in duplicates (N ¼ 4). The statistical difference between the indicated mutant and constitutively active a 13 QL is indicated by asterisks (*Po0.05) Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner N-terminal Myc-His-tagged b 1 g 2 dimers were transfected with a 13 wt and the indicated constructs. The hexahistidine tag on b 1 allowed for the pulldowns of heterotrimeric complexes on Ni-NTA magnetic beads.
Immunoblotting with an anti-HA antibody revealed that a 13 wt bound to Myc-His b 1 g 2 . A control experiment showed that a q was effectively pulled down by b 1 g 2 , whereas a mutant of a q (a q IE), previously reported to be b 1 g 2 -binding defective, did not show any binding (Figure 7 ) (Evanko et al., 2000) . The point mutants a 13 G205S, a 13 K204E, a 13 E229K, a 13 R232E, and the double mutants a 13 K204E/E229K and a 13 E229K/ R232E also bound to Myc-His b 1 g 2 dimers, indicating that these mutations do not affect the structural integrity of a 13 . On the other hand, a 13 K204E/R232E and the triple mutant were deficient in their binding ability (data not shown). Next, we wanted to determine whether our mutants could interact with a 13 effectors other than p115Rho-GEF. It has been demonstrated that activated a 13 interacts with Ser/Thr protein phosphatase type 5 (PP5) through its TPR (Yamaguchi et al., 2002 (Yamaguchi et al., , 2003 . The purified TPR domain of PP5 fused to GST (GST-TPR) on glutathione agarose beads was incubated with COS-7 cell lysates expressing constitutively activated a 13 or mutants. As expected, a 13 QL was pulled down by GST-TPR, whereas in a control experiment a q QL did not show any binding, confirming that this interaction is specific for a 13 (Yamaguchi et al., 2002) . The point mutants a 13 K204E QL, a 13 E229K QL, and a 13 R232E QL also bound to GST-TPR, indicating that these mutations do not affect the ability of a 13 to interact with an effector other than p115RhoGEF.
Discussion
Based on sequence alignment of a 13 with a i1 , and the crystal structure of a i1 /RGS4 complex, we predicted a 13 residues Lys204, Glu229, and Arg232 to be important for the a 13 /p115RhoGEF interaction (Tesmer et al., 1997) . Herein, we demonstrate that mutating each of these three amino acids to opposite charge residues disrupts the interaction of activated a 13 with the RH domain of p115RhoGEF or full-length p115RhoGEF. We also demonstrate that it is only amino-acid Glu229 in a 13 , that when mutated to an opposite charge lysine strongly disrupts the ability of activated a 13 to induce the recruitment of p115RhoGEF to the PM and to activate Rho-dependent signaling. Though a 13 K204E and a 13 R232E are deficient in binding p115RhoGEF, they induce at least partial recruitment of p115RhoGEF to the PM. Moreover, both a 13 K204E and a 13 R232E retain some ability to activate Rho-dependent signaling. Another mutation, G205S, has no effect on the ability of a 13 to interact with p115RhoGEF, even though cognate Gly to Ser mutations in several other a subunits have been shown to confer resistance to interacting with RGS proteins. Consistent with previous studies focusing on mutational analyses of p115RhoGEF, our results indicate that the a 13 /p115RhoGEF interaction shares common features with other known a/RGS interactions, but also has notable differences Wedegaertner, 2000, 2003a, b; Chen et al., 2001 Chen et al., , 2003 Nakamura et al., 2004) .
The a 13 mutations K204E and R232E cause decreased interaction with p115RhoGEF (Figures 2-4) , and these results are consistent with the critical role demonstrated for a i1 residues at identical positions in mediating interaction with RGS4 (Tesmer et al., 1997) . Lys204 and Arg232 in a 13 correspond to a i1 amino acids Thr182 and Lys210, respectively. Both Thr182 and Lys210 of a i1 make extensive contacts with RGS4 residues (Tesmer et al., 1997) . Our results showing greatly decreased interaction of a 13 K204E and a 13 R232E with p115Rho-GEF suggest that a 13 and a i1 utilize similar surfaces to interact with p115RhoGEF and RGS4, respectively. Nonetheless, Lys204 and Arg232 in a 13 are structurally distinct from a i1 residues Thr182 and Lys210, particularly Lys204 versus Thr182, and thus the specific contacts in a 13 /p115RhoGEF and a i1 /RGS4 will be distinct. An interesting difference between Lys204 and Arg232 is that mutation to an opposite-charge glutamic acid, as in a 13 K204E and a 13 R232E, strongly disrupts interaction with the RH domain of p115RhoGEF or full-length p115RhoGEF, but when mutated to alanine only a 13 K204A loses interaction with the RH domain of p115RhoGEF; a 13 R232A retains efficient activationdependent GST pulldown with the RH domain of p115RhoGEF (Figure 2) .
Although a 13 K204E and a 13 R232E were strongly deficient in their ability to interact with p115RhoGEF, both constitutively active forms, a 13 K204E QL and a 13 R232E QL, displayed only a partial defect in Rhodependent signaling (Figure 6 ). Moreover, a 13 K204E QL retained the ability to promote PM recruitment of Ga 13 residues that determine interaction with p115RhoGEF E Grabocka and PB Wedegaertner p115RhoGEF, while a 13 R232E QL was partially impaired ( Figure 5 ). It is possible that weak interaction of these mutants with p115RhoGEF inside cells may be sufficient to translocate p115RhoGEF to the PM and to activate Rho-dependent signaling.
The lack of effect of the G205S mutation in a 13 is distinct from the RGS-insensitive phenotype observed for identical Gly to Ser mutations in most other Ga Lan et al., 1998) , and thus, results with a 13 G205S provide further evidence for differences between the a 13 /p115RhoGEF interaction and other canonical Ga/RGS interactions. However, the a 13 / p115RhoGEF pair is not the only case in which a Gly to Ser mutation at this Ga position fails to affect the interaction; a recent report demonstrated that such a Gly to Ser mutant of a q , a q G188S, retains interaction with the RH domain of GRK2 even though it loses interaction with RGS2 (Sterne-Marr et al., 2003) .
The results presented here suggest that Glu229 is particularly crucial for a 13 to bind to and activate p115RhoGEF. Like a 13 K204E and a 13 R232E, a 13 E229K loses activation-dependent interaction with p115RhoGEF ( Figures 2-4) but, in contrast to constitutively active a 13 K204E QL and a 13 R232E QL, a 13 E229K QL is strongly deficient in recruiting p115RhoGEF to the PM and in activating Rho signaling (Figures 5 and 6) . A glutamic acid at positions identical to 229 in a 13 is conserved in all Ga, and the identical Glu207 in a i1 makes critical intramolecular contacts and numerous contacts with residues in RGS4 (Tesmer et al., 1997) . Although a 13 E229K was disrupted in all p115RhoGEF interaction assays, including PM recruitment of p115RhoGEF and activation of Rho signaling, it retained the ability to properly localize at the PM and to interact with b 1 g 2 and the TPR domain of PP5 in pulldown assays (Figures 7 and 8) , suggesting that the E229K mutation does not cause a global disruption of proper folding of a 13 . In contrast to a 13 E229K, the a 13 E229A mutant retained interaction with p115RhoGEF (Figures 2 and 4) , suggesting that Glu229 functions predominantly in charge complementarity interactions.
A potential role for Glu229 of a 13 in stabilizing and orienting other p115RhoGEF-interacting amino acids of a 13 is revealed by the gain of function of the constitutively active double mutants a 13 K204E/E229K QL and a 13 E229K/R232E QL. Such a role is consistent with the structure of the a i1 /RGS4 complex, in which Glu207 makes contacts with the side chains of other RGS4-interacting residues of a i1 (Tesmer et al., 1997) . Introduction of the charge reversal mutations K204E or R232E into a 13 E229K QL partially restored the ability of a 13 E229K QL to interact with GST-p115RH, to recruit p115RhoGEF to the PM, and to activate Rho signaling. Rescue of binding to GST-p115RH was only observed in the a 13 QL background; AlF 4 À -activated a 13 K204E/E229K and a 13 E229K/R232E did not interact with GST-p115RH or co-immunoprecipate with p115RhoGEF. The reason for this difference is unclear. Slight structural differences in mutationally activated versus AlF 4 À -activated a 13 or a role for potential binding sites on p115RhoGEF outside of the RH domain (Wells et al., 2002b; Chen et al., 2003) may contribute to an explanation. Nonetheless, the results with a 13 K204E/ E229K QL and a 13 E229K/R232E QL are consistent with charge-charge interactions among a 13 amino acids at the p115RhoGEF-binding interface, with Glu229 playing a major role. Confirmation of this speculation and identification of the exact role for a 13 amino acids tested in this study awaits structural determination of an a 13 /p115RhoGEF complex.
a 13 regulates the activity of several molecules, in addition to the RhoGEFs. Its role in regulating cell growth and differentiation seems to be mediated at least partially by its interaction with p115RhoGEF, or PDZRhoGEF or LARG, and the subsequent activation of Rho. Several additional pathways might be involved in the a 13 -mediated regulation of cell growth and differentiation since a 13 , as previously demonstrated, is a very powerful transformant, whereas Rho is a weak one (Symons, 1996) . Radixin, a member of the ERM family of proteins, and cadherins have also been linked to the transforming ability of a 13 (Vaiskunaite et al., 2000; Meigs et al., 2001 Meigs et al., , 2002 . Other proteins yet to be identified may also play a role. The identification of a 13 mutants defective in their interaction with p115Rho-GEF, ability to activate Rho, and induce recruitment of p115RhoGEF to the PM could provide significant insight into the mechanisms through which a 13 interacts with other effectors and induces transformation.
Materials and methods
Cell culture and transfection HEK293 cells were obtained from A Marchese (Thomas Jefferson University, Philadelphia, PA, USA). HEK293 and COS-7 were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, and penicillin-streptomycin. HEK293 cells stably expressing MycHis epitope tagged b 1 g 2 (DS Evanko, MM Thiyagarajan, S Figure 8 Interaction of constitutively active a 13 mutants with GST-TPR. COS-7 cells were transfected with the indicated a 13 QL constructs (4.5 mg) and pcDNA3 (4.5 mg). a 13 QL or mutants were pulled down with 10 mg of GST-TPR immobilized on glutathione agarose beads. a 13 QL or mutant pulldowns were detected by immunoblotting with anti-HA antibody (upper panel). Cell lysates were immunoblotted with an anti-HA antibody to determine equal expression of a 13 QL mutants (lower panel). Results shown are representative of at least three independent experiments Takida, and PB Wedegaertner, unpublished results) were propagated in DMEM with 10% fetal bovine serum and G418. Unless otherwise noted, cells were plated in 6 cm or six-well plates 24 h prior to transfection. Cells were transfected with either 1 mg of DNA/well of a six-well plate or 3 mg DNA in a 6 cm plate using FuGENE 6 (Roche Diagnostics, Indianapolis, IN, USA), according to manufacturer's protocol.
Expression plasmids
The HA epitope (DVPDYA)-tagged pcDNA3HA a 13 wt and pcDNA3HA a 13 QL were gifts from JS Gutkind (Fukuhara et al., 1999) . pGEX-4T-2 PP5-TPR was a gift from M Negishi (Kyoto University, Kyoto, Japan) (Yamaguchi et al., 2002) . The N-terminal Myc epitope (MEQKLISEED)-tagged pcDNA3Myc p115RhoGEF, and N-terminal Myc-His-epitope-tagged b 1 in pcDNA3 have been described Wedegaertner, 2000, 2003a; Takida and Wedegaertner, 2003) . The Stratagene QuickChange sitedirected mutagenesis kit or Sequential PCR was used to create the K204E, E229K, R232E, K204E/E229K, K204E/R232E, E229K/R232E mutants in both a 13 wt and a 13 QL, and the K204A, E229A, and R232A mutants in a 13 wt. For the generation of the RGS homology domain of p115RhoGEF (p115RH) fused to GST, a fragment of p115RhoGEF containing residues 1-252 was amplified with forward and reverse primers containing a 5
0 EcoRI site and a 3 0 SalI site for subcloning into pGEX-5x-1. The correct DNA sequence of the mutants was confirmed by DNA sequencing of the entire open reading frame (Kimmel Cancer Institute Nucleic Acid Facility). The reporter plasmid that expresses the luciferase gene under the control of SRE, termed pSRE-Luc, was purchased from Stratagene (La Jolla, CA, USA). The plasmids carrying the HA epitope-tagged activated RhoA (pcDNA3 RhoV14) or the b-galactosidase gene (pCMV-b-gal) were obtained from P Tsichlis (Tufts University, Boston, MA, USA). The Myc epitope-tagged C3-transferase (pEF-Myc-C3-transferase) was a gift from A.Hall (University College, London, UK).
Protein purification p115RH (1-252) fused to GST was expressed in transformed Escherichia coli cells (BL21 strain). The TPR domain of PP5 fused to GST was expressed in transformed E. coli cells (DH5a strain). Cells were grown in LB media at 371C to A 600 B0.7 and induced with 0.5 mM isopropyl-1-thiogalactopyranoside at 371C for 2 h. Cells were pelleted by centrifugation and lysed by sonication in PBS with 50 mg/ml PMSF, 1 Â Complete protease inhibitor cocktail (Roche), 2 mg/ml lysozyme, 1% Triton X-100 and 2 mM DTT. Next, suspensions were centrifuged at 15 000 r.p.m. for 30 min at 41C. The supernatants were then incubated with glutathione agarose beads for 1 h at 41C. Beads were washed three times with Buffer A (PBS, 1% Triton X-100, 50 mg/ml PMSF, and 1 mg/ml leupeptin and aprotinin) and three times with Buffer B (PBS, 50 mg/ml PMSF, and 1 mg/ml leupeptin and aprotinin). Following washes, beads were re-suspended in Buffer B. The expressed proteins were resolved by SDS-PAGE. Protein concentration was determined by comparison with bovine serum albumin standards after staining with Comassie brilliant blue.
Immunoprecipitations and GST-binding assays
For co-immunoprecipitations and GST-p115RH interaction assays, HEK293 cells in 6 cm plates were transfected with the indicated constructs for 48 h. For GST-TPR assays, COS-7 cells in 10 cm plates were transfected with the indicated constructs for 24 h. Cells were washed twice with ice-cold PBS and lysed with 0.5 ml of lysis buffer (50 mM HEPES, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA, 2.5 mM MgCL 2 , 1mM dithiothreitol, 25 mM glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, and 5 mg/ml leupeptin and aprotinin). For the AlF 4 À experiments, each cell lysate was divided into two aliquots. One aliquot was treated with 50 mM AlCl 3 , 10 mM MgCl 2 , and 10 mM NaF ( þ AlF 4 À ), and the other was left untreated (ÀAlF 4 À ). At 1 h after lysis at 41C, cells lysates were centrifuged at 13 000 r.p.m. for 3 min. In all, 5 mg of an anti-HA epitope (12CA5) mouse monoclonal antibody (Roche Applied Sciences, Indianapolis, IN, USA) was added, and the supernatants were tumbled for 2 h at 41C. Next, 20 ml of Protein A/G Plus agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added, and samples were tumbled overnight at 41C. GST-pulldown experiments were performed with 10 mg of GST-p115RH (1-252) or 10 mg of GST-TPR immobilized on glutathione agarose beads for 2 h at 41C. Beads were then washed three times with lysis buffer. Bound proteins were eluted in 50 ml of SDS sample buffer and boiled for 5 min. Co-immunoprecipitation and GST-pulldown samples were subjected to SDS-PAGE, transferred to PVDF and probed with 0.1 mg/ml of an anti-Myc epitope (9E10) mouse monoclonal antibody (Covance, Berkeley, CA, USA) or with 0.5 mg/ml 12CA5, followed by horseradish peroxidase-conjugated anti-mouse antibody (Promega, Madison, WI, USA). The blots were visualized using Supersignal West Pico (Pierce Chemical, Rockford, IL, USA).
Ni-NTA pulldown of b 1 HEK293 cells stably expressing N-terminal Myc-His-tagged b 1 g 2 were transfected in six-cm plates with the indicated Ga 13 or Ga q constructs. At 36 h after transfection, cells were washed once with ice-cold PBS and lysed in 0.5 ml of lysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 0.7% Triton X-100, 1 mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 10 mM immidazole, 0.5 mM phenylmethylsulfonyl fluoride, and 2 mg/ml leupeptin and aprotinin). After 1 h of lysis at 41C, nuclei and insoluble material were removed by centrifugation at 13 000 r.p.m. for 3 min. Ni-NTA magnetic agarose beads (10 ml; QIAGEN, Valencia, CA, USA) were added to the clarified lysates and samples were tumbled for 2 h at 41C. Next, the samples were placed on the QIAGEN 12-tube Magnet to pellet the beads. The supernatants were discarded and beads were washed three times with lysis buffer containing 20 mM immidazole. Next, the beads were incubated with lysis buffer containing 250 mM immidazole for 3 min to elute b 1 g 2 and proteins bound to them. Eluates were separated by 10% SDS-PAGE, transferred to PVDF, and immunoblotted with the appropriate antibodies as indicated in figure legends.
Immunofluorescence microscopy
At 24 h after transfection in six-well plates, HEK293 cells were split onto coverslips and then grown for an additional 24 h. Cells were fixed with 3.7% formaldehyde in PBS for 15 min, washed three times with PBS, and permeabilized by incubation in blocking buffer containing TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl), 1% Triton X-100, and 2.5% nonfat milk. Cells were then incubated with 12CA5 mouse monoclonal antibody (5 mg/ml) in blocking buffer for 1 h. Following five washes with blocking buffer, cells were incubated in a 1 : 100 dilution of Alexa Fluor 594 goat anti-mouse (Molecular Probes, Eugene, OR, USA) secondary antibody for 30 min. The cells were then washed five times with TBS/1% Triton X-100 and once with PBS. Warm PBS (1 ml) containing 0.1 mg/ml of DAPI (Molecular Probes, Eugene, OR, USA) was added to the cells for 5 min. The coverslips were washed with PBS, rinsed with distilled water and mounted on glass slides with 20 ml of Prolong Antifade reagent (Molecular Probes, Eugene, OR, USA).
Representative images were acquired using an Olympus BX-61 microscope with an ORCA-ER (Hamamatsu, Bridgewater, NJ, USA) cooled charge-coupled device camera controlled by Slidebook version 4.0 (Intelligent Imaging Innovations, Denver, CO, USA). Images were processed with Adobe Photoshop.
SRE-mediated luciferase gene transcription assay
HEK293 cells were plated in six-well plates in serumsupplemented DMEM for 24 h. Cells were then switched to serum-free DMEM and transfected with 0.05 mg of pSRE-Luc, 0.1 mg pCMV-b-gal, pcDNA3 and a 13 constructs as indicated. At 24 h after transfection, cells were washed with ice-cold PBS and lysed using reporter lysis buffer according to the manufacturer's protocol (Promega, Madison, WI, USA). A volume of 20 ml of the lysates were mixed with 50 ml of the luciferase substrate (Promega, Madison, WI, USA) at room temperature. Luciferase activity was determined by measuring luminescence intensity. The b-galactosidase activities were measured by the colorimetric method and were used to normalize transfection efficiency. All assays were performed in duplicates.
Abbreviations G protein, guanine nucleotide-binding protein; GPCR, G protein-coupled receptor; RGS, regulator of G-protein signaling; RH, regulator of G-protein signaling homology domain; GEF, guanine-nucleotide exchange factor; LARG, leukemiaassociated RhoGEF; GAP, GTPase activating protein; SRE, serum response element; PM, plasma membrane; GRK, GPCR kinase; GFP, green fluorescent protein; HA, hemagglutinin; Ni-NTA, nickel-nitrilotriacetic acid.
